Karen Sims insider trades
Open-market stock purchases and sales by Karen Sims, Chief Medical Officer at Arbutus Biopharma Corp, from SEC Form 4 filings since Jul 10, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ABUS Arbutus Biopharma Corp: 2 sales, last Feb 14, 2025